CD274 and myeloid sarcoma: Consistent with these human studies, animal experiments in the EAE model of MS have shown that genetic ablation or pharmacological blockade of PD-1 or PD-L1 enhances the activation and expansion of T-cells and aggravates pathological alterations in the CNS (Latchman et al., 2001; Salama et al., 2003).